Sara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
Sara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California
-
Narrated by:
-
By:
Sara Tartof and Matan Yechezkel discuss a new article in The Lancet Infectious Diseases about emerging doxycycline resistance against gonorrhoea and its wider implications for the implementation of doxycycline and the prevention of bacterial sexually transmitted infections.
Click here to read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext
The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.
Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall
Podcast editing: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at lancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv